Commitments and Contingencies - Securities Purchase and Licensing Agreement and April 2024 Agreement for Gelclair (Details)			3 Months Ended
	Apr. 12, 2024	Mar. 18, 2024 USD ($) $ / shares shares	Mar. 31, 2025 USD ($)	Mar. 31, 2025 EUR (€)	Mar. 31, 2024 USD ($)
Long-term Purchase Commitment
Initial term of contract			5 years	5 years
Non-refundable license fee			$ 215,040	€ 200,000
Royalty expense			$ 39,000
April 2024 Agreement for Gelclair
Long-term Purchase Commitment
Initial term of contract	5 years		5 years	5 years
Gen
Long-term Purchase Commitment
Issuance of common stock (in shares) | shares		277,778
Purchase price of common stock (per shares) | $ / shares		$ 0.12
Gross proceeds from the issuance of common stock		$ 2,000,000
Deferred revenue recognized as revenue		$ 850,000
License granted			$ 43,000		$ 0
Initial term of contract		5 years